Keyphrases
Lozenges
100%
Phase II Study
100%
Oral mucositis
100%
Bupivacaine
100%
Pain Treatment
33%
Oral Cavity
33%
Topical Lidocaine
22%
Pain Management
22%
Pharynx
22%
Head-and-neck Cancer
11%
Missing Data
11%
Days of Treatment
11%
Group Randomized
11%
Between-group
11%
Pain-relieving Effect
11%
Repeated Administration
11%
Mucositis
11%
Efficacy Analysis
11%
Confidence Interval
11%
Clinically Significant
11%
Design Information
11%
Mean Pain Score
11%
Cancer Patients
11%
Tolerability
11%
Serious Adverse Events
11%
Randomized Controlled Study
11%
Denmark
11%
Intervention Group
11%
Medicine and Dentistry
Bupivacaine
100%
Oral Mucositis
100%
Oral Cavity
75%
Pharynx
50%
Analgesia
50%
Lidocaine
50%
Mucositis
25%
Head and Neck Cancer
25%
Adverse Event
25%
Repeated Drug Dose
25%
Pharmacology, Toxicology and Pharmaceutical Science
Oral Mucositis
100%
Bupivacaine
100%
Lidocaine
50%
Adverse Event
25%
Tolerability
25%
Mucosa Inflammation
25%
Head and Neck Cancer
25%